131 related articles for article (PubMed ID: 23337621)
1. Correlation between micronuclei frequency in peripheral blood lymphocytes and retention of 131-I in thyroid cancer patients.
Vrndić OB; Milošević-Djordjević OM; Mijatović Teodorović LC; Jeremić MZ; Stošić IM; Grujicić DV; Zivancević Simonović ST
Tohoku J Exp Med; 2013 Feb; 229(2):115-24. PubMed ID: 23337621
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine therapy accelerates apoptosis in peripheral blood lymphocytes of patients with differentiated thyroid cancer.
Vrndic O; Milosevic-Djordjevic O; Djurdjevic P; Jovanovic D; Mijatovic L; Jeftic I; Simonovic SZ
Neoplasma; 2013; 60(5):568-75. PubMed ID: 23790177
[TBL] [Abstract][Full Text] [Related]
3. Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis.
Joseph LJ; Bhartiya US; Raut YS; Kand P; Hawaldar RW; Nair N
Mutat Res; 2009 Apr; 675(1-2):35-40. PubMed ID: 19386245
[TBL] [Abstract][Full Text] [Related]
4. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.
S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
[TBL] [Abstract][Full Text] [Related]
5. Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131.
Ballardin M; Gemignani F; Bodei L; Mariani G; Ferdeghini M; Rossi AM; Migliore L; Barale R
Mutat Res; 2002 Feb; 514(1-2):77-85. PubMed ID: 11815246
[TBL] [Abstract][Full Text] [Related]
6. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
[TBL] [Abstract][Full Text] [Related]
7. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
8. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
Zakavi SR; Kakhki VD
Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
[No Abstract] [Full Text] [Related]
9. Effect of in vivo exposure to iodine-131 on the frequency and persistence of micronuclei in human lymphocytes.
Livingston GK; Foster AE; Elson HR
J Toxicol Environ Health; 1993; 40(2-3):367-75. PubMed ID: 8230307
[TBL] [Abstract][Full Text] [Related]
10. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
Bhargava P; Choi WS
Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
[No Abstract] [Full Text] [Related]
11. Radioiodine-induced changes in lymphocyte subsets in patients with differentiated thyroid carcinoma.
Tofani A; Sciuto R; Cioffi RP; Pasqualoni R; Rea S; Festa A; Gandolfo GM; Arista MC; Maini CL
Eur J Nucl Med; 1999 Aug; 26(8):824-9. PubMed ID: 10436194
[TBL] [Abstract][Full Text] [Related]
12. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
13. The study of influence factors on (131)I treatment of differentiated thyroid carcinoma with lymph node metastases.
Ye ZY; Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC
Clin Imaging; 2009; 33(3):221-5. PubMed ID: 19411029
[TBL] [Abstract][Full Text] [Related]
14. Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.
Popova L; Hadjidekova V; Hadjieva T; Agova S; Vasilev I
Hell J Nucl Med; 2005; 8(1):54-7. PubMed ID: 15886755
[TBL] [Abstract][Full Text] [Related]
15. The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131.
Dardano A; Ballardin M; Caraccio N; Boni G; Traino C; Mariani G; Ferdeghini M; Barale R; Monzani F
Thyroid; 2012 Mar; 22(3):318-24. PubMed ID: 22181338
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test.
Gutiérrez S; Carbonell E; Galofré P; Creus A; Marcos R
Eur J Nucl Med; 1999 Dec; 26(12):1589-96. PubMed ID: 10638411
[TBL] [Abstract][Full Text] [Related]
17. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
Gerard SK; Dam HQ
Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
[No Abstract] [Full Text] [Related]
18. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Dam HQ; Kim SM; Lin HC; Intenzo CM
Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
[TBL] [Abstract][Full Text] [Related]
19. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
[TBL] [Abstract][Full Text] [Related]
20. Micronucleus formation in lymphocytes of children from the vicinity of Chernobyl after (131)I therapy.
Müller WU; Dietl S; Wuttke K; Reiners C; Biko J; Demidchik E; Streffer C
Radiat Environ Biophys; 2004 May; 43(1):7-13. PubMed ID: 15071746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
